Research Grade Anti-SARS-CoV-2 RBD Antibody (VIR-7229)Anti-SARS-CoV-2 RBD Antibody (VIR-7229) ( VK565566 ) is a research-grade recombinant antibody targeting Receptor-Binding Domain . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | SARS-CoV-2 | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | Receptor-Binding Domain, RBD, Spike glycoprotein, S glycoprotein, Peplomer protein, Spike protein S1, S | | Accession | P0DTC2 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-702-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-SARS-CoV-2 RBD Antibody (VIR-7229). Примечание: |
|